Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.64 |
| ▸ | PPARG | P37231 | 7/20 | 0.64 |
| ▸ | PPARD | Q03181 | 7/20 | 0.64 |
| ▸ | PPARA | Q07869 | 7/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.64 |
| ▸ | TSHR | P16473 | 4/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | TLR2 | O60603 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | FABP4 | P15090 | 2/20 | 0.64 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.64 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | ESR1 | P03372 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | PDE4A | P27815 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5455915 | 1.00 | GPR84 (0.64) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5453095 | 1.00 | GPR84 (0.64) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5456917 | 1.00 | GPR84 (0.64) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5453928 | 1.00 | GPR84 (0.64) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5459522 | 1.00 | GPR84 (0.64) | GPR84PPARGPPARDPPARAHDAC11 | |
| Hydrochloric Acid SCHEMBL3209532 | 0.98 | BBOX1 (0.63) | GPR84PPARGPPARDPPARAHDAC11 | |
| Didecyldimethylammonium SCHEMBL381738 | 0.96 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL18237024 | 0.96 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL5463837 | 0.96 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL8332393 | 0.96 | GPR84 (0.71) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022081046-A1 | CHEMICAL COMPOUND COMPRISING A TRIAZINE GROUP AND METHOD FOR PRODUCING SAME | КУПРЮШКИН, Максим Сергеевич | 2022-04-21 | — | — | WO | claimed |
| US-20070269843-A1 | Diagnostic Assays That Use Mycobacteriophages | INTEGRATED RESEARCH TECHNOLOGY, LLC. | 2007-11-22 | — | — | US | claimed |
| US-7067500-B2 | Betaines as adjuvants to susceptibility testing and antimicrobial therapy | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 2006-06-27 | — | — | US | claimed |
| WO-2005116243-A2 | IMPROVEMENTS TO DIAGNOSTIC ASSAYS THAT USE MYCOBACTERIOPHAGES | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 2005-12-08 | — | — | WO | claimed |
| EP-0756633-B1 | METHOD AND KITS FOR PROCESSING MYCOBACTERIA AND MYCOLIC ACID CONTAINING BACTERIA | INTEGRATED RES TECHNOLOGY LLC (US) | 2005-06-08 | — | — | EP | claimed |
| EP-0980438-A4 | BETAINES AS ADJUDVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | INTEGRATED RES TECHNOLOGY LLC (US) | 2004-10-27 | — | — | EP | claimed |
| US-20030104513-A1 | Betaines as adjuvants to susceptibility testing and antimicrobial therapy | INTEGRATED RESEARCH TECHNOLOGY, LLC | 2003-06-05 | — | — | US | claimed |
| US-6406880-B1 | MYCOLIC ACID STRUCTURE IN OUTER MEMBRANE, ANTIBIOTIC AND BETAINE | INTEGRATED RESEARCH TECHNOLOGY, LLC | 2002-06-18 | — | — | US | claimed |
| EP-0980438-A1 | BETAINES AS ADJUDVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | Integrated Research Technology, LLC (US) | 2000-02-23 | — | — | EP | claimed |
| US-5985593-A | DETERMINATION OF MICROORGANISM CONTAINING MYCOLIC ACID IN EXTERIOR MEMBRANE; ENZYME LYSIS | INTEGRATED RESEARCH TECHNOLOGY, L.L.C. (US) | 1999-11-16 | — | — | US | claimed |
| WO-1998050576-A1 | BETAINES AS ADJUVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 1998-11-12 | — | — | WO | claimed |
| US-5658749-A | DECREASING THE BUOYANCY OF MICROORGANISMS CONTAINING MYCOLIC ACID-LIKE STRUCTURES IN THE OUTER MEMBRANE USING A SOLUTION OF AN SB-18-LIKE OR ROD-LIKE DETERGENT; AMPHOTERIC SURFACTANTS; MEDICAL DIAGNOSIS; CULTURES; AMPLIFICATION | CORNING CLINICAL LABORATORIES, INC. (US) | 1997-08-19 | — | — | US | claimed |
| CN-121574193-A | FK 3-based carborane coupling peptide, and preparation method and application thereof | 兰州大学 | 2026-02-27 | — | — | CN | disclosed |
| EP-4626738-A1 | PYROTECHNIC SWITCH FOR AN ELECTRIC VEHICLE | Ticona LLC (US) | 2025-10-08 | — | — | EP | disclosed |
| US-12404293-B2 | Method for producing glycan, building block for gylican synthesis, and compound | NATIONAL UNIVERSITY CORPORATION TOTTORI UNIVERSITY (JP) | 2025-09-02 | — | — | US | disclosed |
| US-12324435-B2 | Combination of novel nitrification inhibitors and herbicides as well as combination of (thio)phosphoric acid triamides and herbicides | BASF SE (DE) | 2025-06-10 | — | — | US | disclosed |
| EP-0942737-A1 | LONG CHAIN CARBOXYBETAINES IN ANTIMICROBIAL FORMULATIONS | Integrated Research Technology, LLC (US) | 1999-09-22 | — | — | EP | disclosed |
| WO-1998050576-A1 | BETAINES AS ADJUVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998016234-A1 | LONG CHAIN CARBOXYBETAINES IN ANTIMICROBIAL FORMULATIONS | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 1998-04-23 | — | — | WO | disclosed |
| US-5658749-A | DECREASING THE BUOYANCY OF MICROORGANISMS CONTAINING MYCOLIC ACID-LIKE STRUCTURES IN THE OUTER MEMBRANE USING A SOLUTION OF AN SB-18-LIKE OR ROD-LIKE DETERGENT; AMPHOTERIC SURFACTANTS; MEDICAL DIAGNOSIS; CULTURES; AMPLIFICATION | CORNING CLINICAL LABORATORIES, INC. (US) | 1997-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12324435-B2 | Combination of novel nitrification inhibitors and herbicides as well as combination of (thio)phosphoric acid triamides and herbicides | NMT2, NAPRT, NAMPT | GPR84 1238/4885PPARG 262/4885PPARD 464/4885 |
| US-12404293-B2 | Method for producing glycan, building block for gylican synthesis, and compound | OSTC, GYPA, AGL | GPR84 2324/4885PPARG 3200/4885PPARD 4023/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.